Yair Fisher
Chief Tech/Sci/R&D Officer at Glixogen Therapeutics Ltd.
Profile
Yair Fisher is currently the Chief Scientific Officer at GliXogen Therapeutics Ltd.
He holds a doctorate degree from Ben-Gurion University of the Negev.
Yair Fisher active positions
| Companies | Position | Start |
|---|---|---|
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 2018-11-30 |
Training of Yair Fisher
| Ben-Gurion University of the Negev | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
- Stock Market
- Insiders
- Yair Fisher
